Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Re: Year end
23
Dec 30, 2015 05:52AM
8
Dec 30, 2015 07:12AM
4
Dec 30, 2015 11:02AM
2
Dec 30, 2015 11:16AM
6
Dec 30, 2015 11:19AM
40
Dec 30, 2015 11:42AM
10
Dec 30, 2015 11:52AM
8
Dec 30, 2015 12:17PM
10
Dec 30, 2015 01:05PM
5
Dec 30, 2015 02:14PM
3
Dec 30, 2015 02:26PM
12
Dec 30, 2015 02:44PM

Thanks kooter33 for the info. You are rigth! :-)

I only want to remark with my previous comment that I compare POET to a Biotech Company in Phase III previous to recieve the FDA approval for the drug. So, in these Bio companies, normally, the day a day volume is measured in K shares. The "D day" when the drug is approved, the new volume ratio is measured in Millions including a positive SP gap.

I think this can happen to POET some day on 2016 and I hope see +60% in our SP. Fortunately , I can wait for that day. I'm very patient. Always IMHO.

GLTA

3
Dec 30, 2015 04:01PM
6
Dec 31, 2015 01:27PM
Share
New Message
Please login to post a reply